The findings indicate that NGAL measurements could serve as an early biomarker for kidney injury in obese patients with insulin resistance, even in the absence of diabetes and microalbuminuria, and that these patients are at risk of early kidney damage [65]. The gene discussed is LCN2; the disease is Insulin resistance.